BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it is scheduled to present at the Rodman & Renshaw Annual Global Investment Conference on September 15, 2010, at 11:40 AM ET, in the Fahnestock Salon, 5th Floor, at the New York Palace Hotel in New York.
